1. Long term adverse effects of oral contraceptives

   Newsletter Article 08 February 2013 Pages: 2 - 2

2. Theophylline-induced behavioural and learning problems

   Newsletter Article 08 February 2013 Pages: 2 - 3

3. Antidepressant-induced mania

   Newsletter Article 08 February 2013 Pages: 3 - 3

4. Amiodarone

   Newsletter Article 08 February 2013 Pages: 3 - 4

5. Ampicillin

   Newsletter Article 08 February 2013 Pages: 4 - 4

6. Anticoagulants

   Newsletter Article 08 February 2013 Pages: 4 - 4

7. Atenolol

   Newsletter Article 08 February 2013 Pages: 4 - 4

8. Benoxaprofen

   Newsletter Article 08 February 2013 Pages: 4 - 5

9. Chemotherapeutic agents

   Newsletter Article 08 February 2013 Pages: 5 - 5

10. Choline magnesium trisalicylate

    Newsletter Article 08 February 2013 Pages: 5 - 5

11. Cisplatin see Chemotherapeutic agents

    Newsletter Article 08 February 2013 Pages: 5 - 5

12. Cyclosporin/nifedipine

    Newsletter Article 08 February 2013 Pages: 5 - 5

13. Cyproheptadine interaction see Phenelzine interaction

    Newsletter Article 08 February 2013 Pages: 5 - 5

14. Dacarbazine see Chemotherapeutic agents

    Newsletter Article 08 February 2013 Pages: 5 - 5

15. Dactinomycin see Chemotherapeutic agents

    Newsletter Article 08 February 2013 Pages: 5 - 5

16. Desipramine interactions see Phenytoin interaction

    Newsletter Article 08 February 2013 Pages: 5 - 5

17. Doxorubicin see Chemotherapeutic agents

    Newsletter Article 08 February 2013 Pages: 5 - 5

18. Doxorubicin see Mitomycin/doxorubicin

    Newsletter Article 08 February 2013 Pages: 5 - 5

19. Enalapril see Quinapril

    Newsletter Article 08 February 2013 Pages: 5 - 5

20. Etretinate

    Newsletter Article 08 February 2013 Pages: 6 - 6

21. Fenbufen

    Newsletter Article 08 February 2013 Pages: 6 - 6

22. Flecainide

    Newsletter Article 08 February 2013 Pages: 6 - 6

23. Floxuridine/fluorouracil

    Newsletter Article 08 February 2013 Pages: 6 - 6

24. Fluorouracil see Chemotherapeutic agents

    Newsletter Article 08 February 2013 Pages: 7 - 7

25. Fluorouracil see Floxuridine

    Newsletter Article 08 February 2013 Pages: 7 - 7

26. Fluphenazine see Trifluoperazine

    Newsletter Article 08 February 2013 Pages: 7 - 7

27. Glucagon

    Newsletter Article 08 February 2013 Pages: 7 - 7

28. Halothane

    Newsletter Article 08 February 2013 Pages: 7 - 7

29. Imipramine

    Newsletter Article 08 February 2013 Pages: 7 - 7

30. Imipramine see Lithium interaction

    Newsletter Article 08 February 2013 Pages: 7 - 7

31. Lindane

    Newsletter Article 08 February 2013 Pages: 7 - 7

32. Lithium interaction

    Newsletter Article 08 February 2013 Pages: 7 - 8

33. Lithium interaction see Verapamil interaction

    Newsletter Article 08 February 2013 Pages: 8 - 8

34. Metoclopramide

    Newsletter Article 08 February 2013 Pages: 8 - 8

35. Mitomycin/doxorubicin

    Newsletter Article 08 February 2013 Pages: 8 - 8

36. Nalidixic acid

    Newsletter Article 08 February 2013 Pages: 8 - 8

37. Nifedipine

    Newsletter Article 08 February 2013 Pages: 8 - 9

38. Nifedipine see Cyclosporin

    Newsletter Article 08 February 2013 Pages: 9 - 9

39. Oxolinic acid

    Newsletter Article 08 February 2013 Pages: 9 - 9

40. Peppermint oil

    Newsletter Article 08 February 2013 Pages: 9 - 9

41. Pethidine

    Newsletter Article 08 February 2013 Pages: 9 - 10

42. Phenelzine interaction

    Newsletter Article 08 February 2013 Pages: 10 - 10

43. Phenytoin interaction

    Newsletter Article 08 February 2013 Pages: 10 - 10

44. Piroxicam

    Newsletter Article 08 February 2013 Pages: 10 - 10

45. Polymixin B

    Newsletter Article 08 February 2013 Pages: 10 - 11

46. Proguanil

    Newsletter Article 08 February 2013 Pages: 11 - 11

47. Propranolol

    Newsletter Article 08 February 2013 Pages: 11 - 11

48. Propranolol interaction see Verapamil interaction

    Newsletter Article 08 February 2013 Pages: 11 - 11

49. Quinapril/enalapril

    Newsletter Article 08 February 2013 Pages: 11 - 11

50. Salbutamol

    Newsletter Article 08 February 2013 Pages: 11 - 11